(Q47344131)

14 January 2018

title

Naturalistic impact of second-generation antipsychotics on weight gain (English)

1 reference

14 January 2018

1 reference

Diana I Brixner

1

1 reference

14 January 2018

Qayyim Said

2

1 reference

14 January 2018

Patricia K Corey-Lisle

3

1 reference

14 January 2018

A Vickie Tuomari

4

1 reference

14 January 2018

Gilbert J L'italien

5

1 reference

14 January 2018

William Stockdale

6

1 reference

14 January 2018

Gary M Oderda

7

1 reference

14 January 2018

language of work or name

English

0 references

publication date

28 March 2006

1 reference

14 January 2018

Annals of Pharmacotherapy

published in

1 reference

14 January 2018

volume

40

1 reference

14 January 2018

issue

4

1 reference

14 January 2018

page(s)

626-632

1 reference

14 January 2018

Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot

cites work

1 reference

A history of antipsychotic drug development

21 January 2018

1 reference

Pharmacologic treatment of schizophrenia.

21 January 2018

1 reference

Efficacy review of antipsychotics

21 January 2018

1 reference

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

21 January 2018

1 reference

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

21 January 2018

1 reference

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

21 January 2018

1 reference

Metabolic risk during antipsychotic treatment

21 January 2018

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

21 January 2018

1 reference

Atypical antipsychotic induced weight gain: pathophysiology and management

21 January 2018

1 reference

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

21 January 2018

1 reference

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

Combined influence of body mass index and waist circumference on coronary artery disease risk factors among children and adolescents

21 January 2018

1 reference

Head-to-head comparison of the costs of atypical antipsychotics: a systematic review

21 January 2018

1 reference

Coding guidelines for ICD-9 section on mental disorders and reliability of chart clinical diagnoses.

21 January 2018

1 reference

Public attitudes to people with depression: have there been any changes over the last decade?

21 January 2018

1 reference

Relationship between perceived stigma and depression severity.

21 January 2018

1 reference

Perception of stigma among patients with schizophrenia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G564

1 reference

14 January 2018

1 reference

14 January 2018